G. Karlsson - Concepedia

Author

G. Karlsson

Also Known As

G Karlsson, G. KARLSSON, G. Karlsson, G�ril Karlsson

Publications

344

Citations

H-Index

Concepts

All Affiliations

G. Karlsson is an author at Novartis (Switzerland) specializing in medicine, neuroscience, and neuropharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	339
2	Neuroscience	4	4	185
3	Pharmacology	3	3	151
4	Social Sciences	2	2	100
5	Neurology	2	2	100

G. Karlsson

Publications

339

Citations

H-Index

Page 1

	Year	Citations
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events F Mindlen, Roberto Nordaby, M I Soto Ruiz, Queensland's institutional digital repository (The University of Queensland) Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials	1996	154
GABAB receptors in various in vitro and in vivo models of epilepsy: A study with the GABAB receptor blocker CGP 35348 G. Karlsson, C Kolb, A. Hausdorf, Neuroscience Gabab ReceptorsVivo ModelsNeurobiology Of DiseaseNeurophysiologyMedicine	1992	66
The effects of baclofen and two GABAB-receptor antagonists on long-term potentiation Hans-Rudolf Olpe, G. Karlsson Naunyn-Schmiedeberg s Archives of Pharmacology Functional SelectivityMedicinePhysiologyPharmacological AgentNeuropharmacology	1990	66
Late inhibitory postsynaptic potentials in rat prefrontal cortex may be mediated by GABAB receptors G. Karlsson, H.-R. Olpe Cellular and Molecular Life Sciences Gabab ReceptorsSynaptic PlasticityNeurobiological MechanismNeurophysiologyNeuroanatomy	1989	34
Blockade of GABAB receptors accelerates amygdala kindling development G. Karlsson, K. Klebs, Thomas Hafner, Cellular and Molecular Life Sciences Gabab ReceptorsNeurobiological MechanismMedicineNeurotransmitterNeuropharmacology	1992	19

Page 1